Ticker: WTS

Watts Water Technologies

Industrials Industrials Industrial - Machinery
Price 391.45
Reco Buy Potential 75 Risk 30 Updated 2026-07-01

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Watts Water Technologies is a leading provider of water quality and flow control solutions. The company specializes in manufacturing products for plumbing, heating, and water quality applications. Its core offerings include valves, fittings, and water treatment systems. Major business segments encompass plumbing and heating, water quality, and industrial applications. The primary revenue sources are derived from sales of these products to residential, commercial, and industrial markets.

Investment Profile

The investment profile of Watts Water Technologies is more aligned with growth investors, given its consistent revenue growth and focus on innovation in water management solutions. The company shows potential for capital appreciation, making it suitable for those seeking long-term gains. Its performance metrics suggest a balanced approach, appealing to investors looking for a mix of growth and stability.

Fundamental metrics (experimental) Updated: 2026-07-01
EPS (TTM) — earnings per share for the last 12 months, $
10.94
Revenue QoQ — quarter-over-quarter revenue growth
8.4%
AI recommendation changes
Date Before After Reason
2026-07-01 Buy Strong momentum and solid revenue growth support bullish outlook.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-30 Barclays Update — → 414 358.93
2026-05-11 Barclays Target Lowered 323 → 317 296.9
2026-05-08 RBC Capital Target Raised 318 → 323 296.6
News Page 1 of 1
Watts Water Technologies KLA Corp SolarEdge Technologies Air Products and Chemicals Abivax Applied Materials Digital Realty AeroVironment Zimmer Biomet

Stocks Making Significant Moves Midday: AeroVironment Reports Earnings Beat, Abivax Shares Surge 40%

Midday trading saw significant movements in various stocks, particularly in the semiconductor sector, which is on track for a record quarter, and biotech firm Abivax, which experienced a substantial surge following positive treatment data.